vs
麦格劳希尔（MH）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是麦格劳希尔的1.4倍（$622.0M vs $434.2M），Royalty Pharma plc净利率更高（34.4% vs -4.7%，领先39.1%），Royalty Pharma plc同比增速更快（4.8% vs -35.1%）
麦格劳希尔是美国知名教育科技企业，面向K12、高等教育及职业领域的师生提供多元教育内容、软件与服务。核心产品包含教材、数字学习工具及自适应技术，助力优化学习体验、提升学习效果，是与霍顿米夫林哈考特、培生教育齐名的全球三大教育出版商之一。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
MH vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.4倍
$434.2M
营收增速更快
RPRX
高出39.9%
-35.1%
净利率更高
RPRX
高出39.1%
-4.7%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $434.2M | $622.0M |
| 净利润 | $-20.2M | $214.2M |
| 毛利率 | 85.3% | — |
| 营业利润率 | 7.0% | 62.4% |
| 净利率 | -4.7% | 34.4% |
| 营收同比 | -35.1% | 4.8% |
| 净利润同比 | -119.2% | 2.9% |
| 每股收益（稀释后） | $-0.11 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MHRPRX
| Q4 25 | $434.2M | $622.0M | ||
| Q3 25 | $669.2M | $609.3M | ||
| Q2 25 | $535.7M | $578.7M | ||
| Q1 25 | — | $568.2M | ||
| Q4 24 | — | $593.6M | ||
| Q3 24 | — | $564.7M | ||
| Q2 24 | — | $537.3M | ||
| Q1 24 | — | $568.0M |
净利润MHRPRX
| Q4 25 | $-20.2M | $214.2M | ||
| Q3 25 | $105.3M | $288.2M | ||
| Q2 25 | $502.0K | $30.2M | ||
| Q1 25 | — | $238.3M | ||
| Q4 24 | — | $208.2M | ||
| Q3 24 | — | $544.0M | ||
| Q2 24 | — | $102.0M | ||
| Q1 24 | — | $4.8M |
毛利率MHRPRX
| Q4 25 | 85.3% | — | ||
| Q3 25 | 79.2% | — | ||
| Q2 25 | 77.0% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率MHRPRX
| Q4 25 | 7.0% | 62.4% | ||
| Q3 25 | 23.4% | 70.1% | ||
| Q2 25 | 18.0% | 36.3% | ||
| Q1 25 | — | 94.0% | ||
| Q4 24 | — | 60.9% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 50.2% | ||
| Q1 24 | — | -13.0% |
净利率MHRPRX
| Q4 25 | -4.7% | 34.4% | ||
| Q3 25 | 15.7% | 47.3% | ||
| Q2 25 | 0.1% | 5.2% | ||
| Q1 25 | — | 41.9% | ||
| Q4 24 | — | 35.1% | ||
| Q3 24 | — | 96.3% | ||
| Q2 24 | — | 19.0% | ||
| Q1 24 | — | 0.8% |
每股收益（稀释后）MHRPRX
| Q4 25 | $-0.11 | $0.49 | ||
| Q3 25 | $0.57 | $0.67 | ||
| Q2 25 | $0.00 | $0.07 | ||
| Q1 25 | — | $0.55 | ||
| Q4 24 | — | $0.46 | ||
| Q3 24 | — | $1.21 | ||
| Q2 24 | — | $0.23 | ||
| Q1 24 | — | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $514.4M | $618.7M |
| 总债务越低越好 | $2.6B | $9.0B |
| 股东权益账面价值 | $775.3M | $9.7B |
| 总资产 | $5.6B | $19.6B |
| 负债/权益比越低杠杆越低 | 3.36× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资MHRPRX
| Q4 25 | $514.4M | $618.7M | ||
| Q3 25 | $463.2M | $938.9M | ||
| Q2 25 | $247.3M | $631.9M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $929.0M | ||
| Q3 24 | — | $950.1M | ||
| Q2 24 | — | $1.8B | ||
| Q1 24 | — | $843.0M |
总债务MHRPRX
| Q4 25 | $2.6B | $9.0B | ||
| Q3 25 | $2.8B | $8.9B | ||
| Q2 25 | $3.2B | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益MHRPRX
| Q4 25 | $775.3M | $9.7B | ||
| Q3 25 | $794.6M | $9.6B | ||
| Q2 25 | $283.3M | $9.5B | ||
| Q1 25 | — | $9.8B | ||
| Q4 24 | — | $10.3B | ||
| Q3 24 | — | $10.3B | ||
| Q2 24 | — | $9.8B | ||
| Q1 24 | — | $9.9B |
总资产MHRPRX
| Q4 25 | $5.6B | $19.6B | ||
| Q3 25 | $6.0B | $19.3B | ||
| Q2 25 | $5.7B | $18.3B | ||
| Q1 25 | — | $17.6B | ||
| Q4 24 | — | $18.2B | ||
| Q3 24 | — | $18.0B | ||
| Q2 24 | — | $17.7B | ||
| Q1 24 | — | $16.1B |
负债/权益比MHRPRX
| Q4 25 | 3.36× | 0.92× | ||
| Q3 25 | 3.52× | 0.93× | ||
| Q2 25 | 11.17× | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $309.0M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $285.4M | — |
| 自由现金流率自由现金流/营收 | 65.7% | — |
| 资本支出强度资本支出/营收 | 5.4% | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流MHRPRX
| Q4 25 | $309.0M | $827.1M | ||
| Q3 25 | $265.0M | $702.6M | ||
| Q2 25 | $-96.7M | $364.0M | ||
| Q1 25 | — | $596.1M | ||
| Q4 24 | — | $742.5M | ||
| Q3 24 | — | $703.6M | ||
| Q2 24 | — | $658.2M | ||
| Q1 24 | — | $664.6M |
自由现金流MHRPRX
| Q4 25 | $285.4M | — | ||
| Q3 25 | $243.8M | — | ||
| Q2 25 | $-112.9M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率MHRPRX
| Q4 25 | 65.7% | — | ||
| Q3 25 | 36.4% | — | ||
| Q2 25 | -21.1% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度MHRPRX
| Q4 25 | 5.4% | — | ||
| Q3 25 | 3.2% | — | ||
| Q2 25 | 3.0% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率MHRPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | 2.52× | 2.44× | ||
| Q2 25 | -192.53× | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MH
| Higher Education | $225.4M | 52% |
| Digital | $103.5M | 24% |
| Other | $44.4M | 10% |
| Global Professional | $36.2M | 8% |
| $24.7M | 6% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
